questionText: To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to ringfence the supply of glucagon-like peptide 1 agonists medication for patients with type 2 diabetes.
answerText: We are aware of a supply issue with glucagon-like peptide-1 receptor agonists, which has been largely driven by off-label use for weight loss. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July, issued a National Patient ...
heading: Diabetes: Drugs